Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 11/6/17 → 2/7/25 |
Funding
- Veloxis Pharmaceuticals Incorporated: $197,880.00
Impact of Envarsus XR on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- Gedaly, Roberto (PI)
- Marti, Francesc (CoI)
- Rendulic, Tris (CoI)
- Berger, Jonathan (Former CoI)